Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.

<h4>Background</h4>Pulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes. This study aimed to identify the clinical characteristics and risk factors associated with pulmo...

Full description

Saved in:
Bibliographic Details
Main Authors: Junjun Wan, Teng Liu, Fang Li, Shaohua Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0323624
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849762456514068480
author Junjun Wan
Teng Liu
Fang Li
Shaohua Xu
author_facet Junjun Wan
Teng Liu
Fang Li
Shaohua Xu
author_sort Junjun Wan
collection DOAJ
description <h4>Background</h4>Pulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes. This study aimed to identify the clinical characteristics and risk factors associated with pulmonary mucormycosis outcomes in a Chinese cohort.<h4>Materials and methods</h4>A retrospective analysis was conducted on 37 patients diagnosed with pulmonary mucormycosis, focusing on clinical records, laboratory findings, and computed tomography (CT) imaging. Diagnosis was primarily based on histopathology or next-generation sequencing.<h4>Results</h4>The median age of the patients was 55 years, and the most common underlying conditions were hematological malignancies, diabetes, and organ transplantation. Imaging frequently revealed bilateral lung involvement with ground-glass opacities and nodular lesions. The overall mortality rate was 29.7%, with significant risk factors for 90-day mortality including hypertension (Hazard Ratio [HR] = 3.36, 95% Confidence Interval [CI] = 1.01-11.12, P = 0.048), organ transplantation (HR = 4.93, 95% CI = 1.48-16.4, P = 0.009), and immunosuppression (HR = 8.83, 95% CI = 1.13-69.14, P = 0.038).<h4>Conclusions</h4>Early suspicion and timely diagnostic measures, such as biopsy or metagenomic sequencing, are crucial for improving patient outcomes. These findings underscore the importance of recognizing and managing pulmonary mucormycosis in high-risk populations.
format Article
id doaj-art-112d6bde8bd64a65b3cc4e214fd8b8de
institution DOAJ
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-112d6bde8bd64a65b3cc4e214fd8b8de2025-08-20T03:05:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e032362410.1371/journal.pone.0323624Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.Junjun WanTeng LiuFang LiShaohua Xu<h4>Background</h4>Pulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes. This study aimed to identify the clinical characteristics and risk factors associated with pulmonary mucormycosis outcomes in a Chinese cohort.<h4>Materials and methods</h4>A retrospective analysis was conducted on 37 patients diagnosed with pulmonary mucormycosis, focusing on clinical records, laboratory findings, and computed tomography (CT) imaging. Diagnosis was primarily based on histopathology or next-generation sequencing.<h4>Results</h4>The median age of the patients was 55 years, and the most common underlying conditions were hematological malignancies, diabetes, and organ transplantation. Imaging frequently revealed bilateral lung involvement with ground-glass opacities and nodular lesions. The overall mortality rate was 29.7%, with significant risk factors for 90-day mortality including hypertension (Hazard Ratio [HR] = 3.36, 95% Confidence Interval [CI] = 1.01-11.12, P = 0.048), organ transplantation (HR = 4.93, 95% CI = 1.48-16.4, P = 0.009), and immunosuppression (HR = 8.83, 95% CI = 1.13-69.14, P = 0.038).<h4>Conclusions</h4>Early suspicion and timely diagnostic measures, such as biopsy or metagenomic sequencing, are crucial for improving patient outcomes. These findings underscore the importance of recognizing and managing pulmonary mucormycosis in high-risk populations.https://doi.org/10.1371/journal.pone.0323624
spellingShingle Junjun Wan
Teng Liu
Fang Li
Shaohua Xu
Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
PLoS ONE
title Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
title_full Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
title_fullStr Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
title_full_unstemmed Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
title_short Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis.
title_sort diagnosis clinical features and mortality risk factors in a chinese cohort with pulmonary mucormycosis
url https://doi.org/10.1371/journal.pone.0323624
work_keys_str_mv AT junjunwan diagnosisclinicalfeaturesandmortalityriskfactorsinachinesecohortwithpulmonarymucormycosis
AT tengliu diagnosisclinicalfeaturesandmortalityriskfactorsinachinesecohortwithpulmonarymucormycosis
AT fangli diagnosisclinicalfeaturesandmortalityriskfactorsinachinesecohortwithpulmonarymucormycosis
AT shaohuaxu diagnosisclinicalfeaturesandmortalityriskfactorsinachinesecohortwithpulmonarymucormycosis